GALANIN RECEPTOR LIGANDS AS POTENTIAL THERAPEUTIC AGENTS IN DEPRESSION AND NEURODEGENERATION

被引:0
|
作者
BARTFAI, T
LANGEL, U
机构
关键词
GALANIN; RECEPTOR; ANTAGONIST; COGNITION; ANTIDEPRESSANT; NEUROPEPTIDE; SUBTYPES; ACETYLCHOLINE; ALZHEIMERS DISEASE;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:S163 / S174
页数:12
相关论文
共 50 条
  • [21] Galanin as a modulator of anxiety and depression and a therapeutic target for affective disease
    Karlsson, R. -M.
    Holmes, A.
    AMINO ACIDS, 2006, 31 (03) : 231 - 239
  • [22] Purinergic P2X7 receptor as a potential therapeutic target in depression
    Qi, Wang
    Jin, Xiang
    Guan, Wei
    BIOCHEMICAL PHARMACOLOGY, 2024, 219
  • [23] Estrogen receptor β as a therapeutic target for promoting neurogenesis and preventing neurodegeneration
    Zhao, LQ
    Brinton, RD
    DRUG DEVELOPMENT RESEARCH, 2005, 66 (02) : 103 - 117
  • [24] P2X3 Receptor Ligands: Structural Features and Potential Therapeutic Applications
    Spinaci, Andrea
    Buccioni, Michela
    Dal Ben, Diego
    Marucci, Gabriella
    Volpini, Rosaria
    Lambertucci, Catia
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [25] Galanin – 25 years with a multitalented neuropeptideGalanin, galanin receptor subtypes and depression-like behaviour
    E. Kuteeva
    T. Hökfelt
    T. Wardi
    S. O. Ögren
    Cellular and Molecular Life Sciences, 2008, 65 : 1854 - 1863
  • [26] Growth hormone secretagogue receptor antagonists as potential therapeutic agents for obesity
    Zhao, HY
    DRUG DEVELOPMENT RESEARCH, 2005, 65 (02) : 50 - 54
  • [27] Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration
    Kinscherf, Noah Alexander
    Pehar, Mariana
    CURRENT DRUG TARGETS, 2022, 23 (12) : 1191 - 1209
  • [28] Cannabinoid receptor ligands as potential anticancer agents - high hopes for new therapies?
    Oesch, Susanne
    Gertsch, Juerg
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 (07) : 839 - 853
  • [29] Phenotypic assessment of galanin overexpressing and galanin receptor R1 knockout mice in the tail suspension test for depression-related behavior
    Andrew Holmes
    Qian Li
    Elizabeth A. Koenig
    Eric Gold
    Dejaimenay Stephenson
    Rebecca J. Yang
    Jennifer Dreiling
    Tim Sullivan
    Jacqueline N. Crawley
    Psychopharmacology, 2005, 178 : 276 - 285
  • [30] Phenotypic assessment of galanin overexpressing and galanin receptor R1 knockout mice in the tail suspension test for depression-related behavior
    Holmes, A
    Li, Q
    Koenig, EA
    Gold, E
    Stephenson, D
    Yang, RJ
    Dreiling, J
    Sullivan, T
    Crawley, JN
    PSYCHOPHARMACOLOGY, 2005, 178 (2-3) : 276 - 285